Investors

Investor facts

Optos plc is a leading retinal imaging company with a vision to be recognized as the leading provider of retinal diagnostics through leveraging its unique ultra-widefield imaging technology.

Over 30 million optomap exams have been performed worldwide, helping us to secure our leading position in retinal diagnostics

Investor Factsheet

Download April 2012 pdf verions

Download December 2011 pdf version

Download August 2011 pdf version

Download December 2010 pdf version

Download August 2010 pdf version

Download June 2010 pdf version

Download March 2010 pdf version

Download An Introduction to Optos - Building The Retina Company

Quick facts

Founded in 1992, IPO on LSE Main Market 2006. Operations in North America and Europe
Over 34m optomap exams performed to date
Initially, devices used primarily in “wellness screening” to verify eye health. Newer devices with increased functionality used in treatment regimes
82% of Optos’ business is in the North America. We are growing quickly in Europe and expanding into new markets through new distribution channels and directly in Australia
95% of Optos’ revenue is from the core optometry sector with growing presence in ophthalmology
Optos has < 20% market penetration in ‘target sectors’ in existing markets - providing significant growth potential